# Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer

> **NCT01172925** · PHASE2 · UNKNOWN · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 34 (estimated)

## Conditions studied

- NSCLC
- Dyspnea

## Interventions

- **DRUG:** Tiotropium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01172925
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2016-06
- **Final completion:** 2016-08
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2015-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01172925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01172925, "Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01172925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*